Crystal structure of human PDK2 complexed with GM67520 Descriptor: 4-[[[5-[5-chloranyl-2,4-bis(oxidanyl)phenyl]-4-[4-(1-methylsulfonylpiperidin-4-yl)oxyphenyl]-1,2-oxazol-3-yl]carbonylamino]methyl]cyc
We characterized expression profilings of SMYD2 knockdown and control cells treated by BIX-01294 and Rapamycin. Overall design: We used siRNAs to knockdown SMYD2 in HCT116 cells, and NC as control. We
